Stonegate Capital Partners Initiates Coverage on NU Skin Enterprises Inc. (NUS)

Rhea-AI Summary

NU Skin Enterprises (NYSE:NUS) received coverage initiation from Stonegate Capital Partners following strong Q2 2025 performance. The company reported revenue of $386.1M, reaching the high end of their guidance range of $355.0M-$390.0M.

Key highlights include adjusted EPS of $0.43, significantly exceeding guidance of $0.20-$0.30, and adjusted net income growth of 103.5% year-over-year. The company's gross margin expanded 106 basis points quarter-over-quarter to 68.8%. Notable segment performance included Rhyz Manufacturing's 17% revenue growth and Latin America's 107% revenue increase year-over-year.

News Market Reaction – NUS

+18.48%

21 alerts

+18.48% News Effect

+6.6% Peak in 3 hr 41 min

+$71M Valuation Impact

$454M Market Cap

0.9x Rel. Volume

On the day this news was published, NUS gained 18.48%, reflecting a significant positive market reaction. Argus tracked a peak move of +6.6% during that session. Our momentum scanner triggered 21 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $71M to the company's valuation, bringing the market cap to $454M at that time.

Data tracked by StockTitan Argus on the day of publication.

Dallas, Texas--(Newsfile Corp. - August 8, 2025) - Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners initiates their coverage on Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj Net Income, and adj EPS of $386.1M, $21.1M, and $0.43, respectively. Revenue was at the high end of the guidance range, which was $355.0M to $390.0M. Of note was the Rhyz Manufacturing segment which saw 17% year over year revenue growth. EPS outpaced guidance by a significant amount, which was in the range of $0.20 to $0.30. Gross margin was 68.8% for the quarter, reflecting a quarter-over-quarter expansion of 106 bps from 1Q25. This quarter's strong performance was driven by a focus on growing revenue along with operational optimization efforts leading to the strong year-over-year growth of Adj. Net Income of 103.5%. We are encouraged by the continued NI margin expansion as the Company positions itself for a solid 2Q25.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

• Q2 adj. EPS of $0.43 exceeded guidance; adj. net income grew 103.5% y/y.
• Achieved net cash position ahead of schedule; Rhyz Manufacturing revenue up 17% y/y.
• Latin America revenue up 107% y/y; India expansion and Prysm iO device launch on track.

Click image above to view full announcement.

---

About Stonegate

Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/261905

FAQ

What were NU Skin's (NUS) Q2 2025 earnings results?

NU Skin reported revenue of $386.1M, adjusted net income of $21.1M, and adjusted EPS of $0.43, with revenue hitting the high end of guidance range ($355.0M-$390.0M).

How did NU Skin (NUS) perform compared to its Q2 2025 guidance?

NU Skin significantly outperformed guidance, with adjusted EPS of $0.43 exceeding the guidance range of $0.20-$0.30, and revenue reaching the high end of the $355.0M-$390.0M guidance range.

What was NU Skin's (NUS) gross margin in Q2 2025?

NU Skin achieved a gross margin of 68.8%, representing a 106 basis points expansion from Q1 2025.

How did NU Skin's (NUS) Latin America and Rhyz Manufacturing segments perform in Q2 2025?

NU Skin's Latin America revenue grew 107% year-over-year, while the Rhyz Manufacturing segment saw 17% year-over-year revenue growth.

What are the key growth initiatives for NU Skin (NUS) in 2025?

NU Skin is focusing on India expansion and the launch of their Prysm iO device, while continuing operational optimization efforts.